TREA

97042705 - SURGE

Follow

Information

  • Trademark
  • 97042705
  • Serial Number
    97042705
  • Filing Date
    September 23, 2021
    3 years ago
  • Transaction Date
    April 23, 2024
    10 months ago
  • Status Date
    April 23, 2024
    10 months ago
  • Published for Opposition Date
    February 27, 2024
    11 months ago
  • Location Date
    April 23, 2024
    10 months ago
  • Status Code
    688
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    VAUSS, JERAMEY WALLACE
  • Attorney Docket Number
    120292.00042
    Attorney Name
    Sara M. Bauer
    Law Office Assigned Location Code
    L50
  • Owners
Information
Mark Drawing Code
4
Mark Identification
SURGE
Case File Statements
  • GS0051: Hydrogel for medical purposes; Natural biomaterial for delivery of immunotherapy; pharmaceutical preparations used to modulate an immune response; pharmaceutical preparations for the treatment of cancer and for enhancing immune response to tumors; therapeutic agents for impacting immune-stimulating cells; therapeutic agents for impacting immune-suppressive cells; pharmaceutical preparations for the prevention and treatment of oncological, viral, musculoskeletal, immune, autoimmune, blood, respiratory, metabolic, neurological, urological, neoplastic, fibrotic diseases and disorders, and pain; biological preparations for the prevention and treatment of oncological, viral, musculoskeletal, immune, autoimmune, blood, respiratory, metabolic, neurological, urological, neoplastic, fibrotic diseases and disorders, and pain; drug delivery agents in the form of injections for medical purposes for the prevention and treatment of oncological, viral, musculoskeletal, immune, autoimmune, blood, respiratory, metabolic, neurological, urological, neoplastic, fibrotic diseases and disorders, and pain; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; pharmaceutical preparations, namely, biomaterials to extend the release of immunotherapy treatments at the site of tumor resection; Natural intraoperative biomaterial for delivery of immunotherapy
  • GS0101: Artificial biomaterial for delivery of immunotherapy; Artificial intraoperative biomaterial for delivery of immunotherapy
  • GS0421: Research and development in the field of immunotherapy; research and development in the field of oncology; pharmaceutical research and development; providing medical research and scientific research information in the fields of oncology and immunotherapy via a website
Case File Event Statements
  • 9/27/2021 - 3 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 6/24/2022 - 2 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 10/26/2021 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 11/3/2021 - 3 years ago
    3 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN
  • 7/21/2022 - 2 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 7/21/2022 - 2 years ago
    6 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 7/21/2022 - 2 years ago
    7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 10/21/2022 - 2 years ago
    8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 10/21/2022 - 2 years ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 10/22/2022 - 2 years ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 11/14/2022 - 2 years ago
    11 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 11/14/2022 - 2 years ago
    12 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 11/14/2022 - 2 years ago
    13 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 11/14/2022 - 2 years ago
    14 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 11/25/2022 - 2 years ago
    15 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 11/25/2022 - 2 years ago
    16 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 11/25/2022 - 2 years ago
    17 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 6/8/2023 - a year ago
    18 - SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Type: RCCK
  • 6/30/2023 - a year ago
    19 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 6/30/2023 - a year ago
    20 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 6/30/2023 - a year ago
    21 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 8/25/2023 - a year ago
    22 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Type: XELR
  • 8/25/2023 - a year ago
    23 - APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Type: XELG
  • 10/27/2023 - a year ago
    24 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 10/27/2023 - a year ago
    25 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 10/27/2023 - a year ago
    26 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 10/27/2023 - a year ago
    27 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 10/27/2023 - a year ago
    28 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 12/27/2023 - a year ago
    29 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 12/27/2023 - a year ago
    30 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 12/28/2023 - a year ago
    31 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 1/24/2024 - a year ago
    32 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 1/24/2024 - a year ago
    33 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 1/24/2024 - a year ago
    34 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 1/24/2024 - a year ago
    35 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 1/24/2024 - a year ago
    36 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 2/7/2024 - a year ago
    37 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 2/7/2024 - a year ago
    38 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 2/27/2024 - 11 months ago
    39 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 3/4/2024 - 11 months ago
    40 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 4/23/2024 - 10 months ago
    41 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM